Corbus (CRBP) Chief Business Officer buys 13,500 shares in open market
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Corbus Pharmaceuticals Chief Business Officer Nishant C. Saxena bought 13,500 shares of common stock in open-market transactions. He purchased 9,000 shares at $7.58 per share on June 3 and 4,500 shares at a weighted average price of $7.33 per share on June 2, in multiple trades between $7.33 and $7.34. Following these purchases, he directly holds 75,300 common shares, including 58,300 unvested RSUs that remain subject to the grant’s vesting schedule.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 13,500 shares ($101,219)
Net Buy
2 txns
Insider
Saxena Nishant C
Role
Chief Business Officer
Bought
13,500 shs ($101K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, par value $0.0001 per share | 9,000 | $7.58 | $68K |
| Purchase | Common Stock, par value $0.0001 per share | 4,500 | $7.333 | $33K |
Holdings After Transaction:
Common Stock, par value $0.0001 per share — 75,300 shares (Direct, null)
Footnotes (1)
- The price reported in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.33 to $7.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule as previously reported.
Key Figures
Total shares purchased: 13,500 shares
June 3 purchase: 9,000 shares at $7.58/share
June 2 weighted average price: $7.33/share
+2 more
5 metrics
Total shares purchased
13,500 shares
Open-market buys on June 2–3, 2026
June 3 purchase
9,000 shares at $7.58/share
Common stock open-market purchase
June 2 weighted average price
$7.33/share
4,500 shares bought in multiple trades $7.33–$7.34
Shares owned after transaction
75,300 shares
Direct common stock holdings after June 3, 2026
Unvested RSUs
58,300 RSUs
Remain subject to vesting schedule
Key Terms
open-market purchase, weighted average price, RSUs, vesting schedule
4 terms
open-market purchase financial
"Transaction code P is described as an open-market purchase of common stock."
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported is a weighted average price for trades between $7.33 and $7.34."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
RSUs financial
"This amount includes 58,300 unvested RSUs subject to the grant's vesting schedule."
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
vesting schedule financial
"The 58,300 unvested RSUs remain subject to the grant's vesting schedule as previously reported."
A vesting schedule is a timeline that determines when someone gains full ownership of certain benefits, such as company stock or retirement contributions. Think of it like earning the right to own a gift gradually over time, rather than receiving it all at once. It matters to investors because it affects when they can fully access or sell these benefits, influencing their financial planning and decision-making.
FAQ
What insider transaction did Corbus (CRBP) report for Nishant C. Saxena?
Corbus (CRBP) reported that Chief Business Officer Nishant C. Saxena purchased 13,500 shares of common stock in open-market transactions. These buys occurred on June 2 and June 3, 2026, and increased his direct ownership stake in the company.
How many unvested RSUs does Nishant C. Saxena hold in Corbus (CRBP)?
Nishant C. Saxena holds 58,300 unvested RSUs of Corbus (CRBP), which remain subject to the grant’s vesting schedule. These RSUs represent additional potential shares that will only fully transfer as they vest over time.
Were Nishant C. Saxena’s Corbus (CRBP) purchases made in the open market?
Yes, both transactions were coded as open-market purchases of Corbus (CRBP) common stock. The filing classifies them as non-derivative transactions with transaction code P, indicating purchases in the open market or a private transaction.
What does weighted average price mean in Nishant C. Saxena’s Corbus (CRBP) Form 4?
The weighted average price of $7.33 reflects multiple trades executed between $7.33 and $7.34 for Corbus (CRBP) shares. The insider notes that detailed trade-by-trade pricing information is available to the issuer, security holders, or SEC staff upon request.